Gosselies, Belgium · Founded 2010 · Privately Held (backing)
Operator of a clinical-stage biopharmaceutical company intended to prevent and treat thrombotic and inflammatory diseases. Bioxodes is based in Gosselies, Belgium and was founded in 2010. Its last reported valuation was $116 million in Feb 2025. It has raised $39.1 million.
Last reported valuation
$115.5M
Oct 2026
Priced at
—
Total raised
$39.1M
Last round
—
Cap table — not yet on record
Bioxodes's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Bioxodes with a free account
·The complete investor list: 12 names
·Watch Bioxodes: the Monday email on marks, rounds and moves
